Evofem Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Evofem Biosciences Inc's ROI in the second quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Evofem Biosciences Inc 's return on investment (ROI) in its second quarter of 2026

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-81	-71	-65	-64	-60
Return On Investment (TTM)	-	-	-	-	-
EVFM's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-15	-6	0	-5	-6

EVFM Company Profile >> Back to EVFM Roi Comparisons >> See Annual EVFM Return On Investment

Return On Investment EVFM's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Evofem Biosciences Inc's II. Quarter Investments	$ -81 Millions	EVFM's Balance sheet
Evofem Biosciences Inc's II. Quarter Income	$ -11 Millions	Quarterly EVFM's Income Statement
EVFM's Income by Division		See EVFM's Income by Division

EVFM Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	-65	-57	-62	-69	-100
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	0	-9	50	-78	-206
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EVFM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EVFM's Competitors
Subscribers only: Roi for Evofem Biosciences Inc's Suppliers
Subscribers only: Return On Investment for EVFM's Customers

Other Ratios
EVFM's Roa	EVFM's Inventory Turnover Ratio	EVFM's Growth Rates	EVFM's Dividend Statistics
	EVFM's Profitability Ratios	EVFM's Asset Turnover Ratio	EVFM's Dividend Growth
EVFM's Roe	EVFM's Valuation Ratios	EVFM's Financial Strength Ratios	EVFM's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Meiragtx Holdings Plc	55.83 %
Elite Pharmaceuticals Inc	53.48 %
Idexx Laboratories Inc	51.80 %
Aurinia Pharmaceuticals Inc	50.35 %
Qhslab Inc	48.94 %
Q32 Bio Inc	47.43 %
Vaxart Inc	46.17 %
Liquidia Corporation	42.09 %
Tg Therapeutics Inc	39.26 %
Medpace Holdings Inc	35.54 %
Mettler toledo International Inc	34.41 %
Eli Lilly And Company	33.95 %
Acadia Pharmaceuticals Inc	31.05 %
Caredx Inc	29.42 %
Adma Biologics Inc	28.94 %
Protalix Biotherapeutics inc	25.72 %
Pro dex Inc	24.29 %
Innoviva Inc	23.33 %
Electromed Inc	23.18 %
Zevra Therapeutics Inc	22.90 %
Iradimed Corporation	22.57 %
Alnylam Pharmaceuticals Inc	22.10 %
Eton Pharmaceuticals Inc	21.31 %
Dexcom Inc	20.98 %
Healthcare Services Group Inc	20.93 %
Arcutis Biotherapeutics Inc	20.77 %
Chemed Corporation	20.13 %
Resmed Inc	20.01 %
Halozyme Therapeutics Inc	19.99 %
Vertex Pharmaceuticals Inc	19.97 %

Date modified: 2026-09-26T07:01:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.